<?xml version='1.0' encoding='utf-8'?>
<document id="31411489"><sentence text="Quantification of microdosed oral yohimbine and its major metabolite in human plasma in the picogram range."><entity charOffset="34-43" id="DDI-PubMed.31411489.s1.e0" text="yohimbine" /></sentence><sentence text="Aim: Pharmacokinetics after oral microdosing of the anticipated CYP2D6 substrate yohimbine and its metabolite 11-OH-yohimbine is potentially useful for drug-drug interaction trials and profiling of CYP2D6 enzyme activity"><entity charOffset="81-90" id="DDI-PubMed.31411489.s2.e0" text="yohimbine" /><entity charOffset="110-125" id="DDI-PubMed.31411489.s2.e1" text="11-OH-yohimbine" /><pair ddi="false" e1="DDI-PubMed.31411489.s2.e0" e2="DDI-PubMed.31411489.s2.e0" /><pair ddi="false" e1="DDI-PubMed.31411489.s2.e0" e2="DDI-PubMed.31411489.s2.e1" /></sentence><sentence text=" Materials &amp; methods: We developed an ultrasensitive ultra performance liquid chromatography coupled to tandem mass spectrometry assay for quantification of yohimbine and its main metabolite 11-OH-yohimbine in plasma with a linear calibration range of 5-2500 pg/ml and validated it according to US FDA's and EMA's guidelines"><entity charOffset="157-166" id="DDI-PubMed.31411489.s3.e0" text="yohimbine" /><entity charOffset="191-206" id="DDI-PubMed.31411489.s3.e1" text="11-OH-yohimbine" /><pair ddi="false" e1="DDI-PubMed.31411489.s3.e0" e2="DDI-PubMed.31411489.s3.e0" /><pair ddi="false" e1="DDI-PubMed.31411489.s3.e0" e2="DDI-PubMed.31411489.s3.e1" /></sentence><sentence text=" Sample preparation was performed using fast liquid-liquid extraction" /><sentence text=" The assay was applied for the determination of concentrations of yohimbine and 11-OH-yohimbine in plasma after oral administration of 50 Î¼g yohimbine to two subjects"><entity charOffset="66-75" id="DDI-PubMed.31411489.s5.e0" text="yohimbine" /><entity charOffset="80-95" id="DDI-PubMed.31411489.s5.e1" text="11-OH-yohimbine" /><entity charOffset="141-150" id="DDI-PubMed.31411489.s5.e2" text="yohimbine" /><pair ddi="false" e1="DDI-PubMed.31411489.s5.e0" e2="DDI-PubMed.31411489.s5.e0" /><pair ddi="false" e1="DDI-PubMed.31411489.s5.e0" e2="DDI-PubMed.31411489.s5.e1" /><pair ddi="false" e1="DDI-PubMed.31411489.s5.e0" e2="DDI-PubMed.31411489.s5.e2" /><pair ddi="false" e1="DDI-PubMed.31411489.s5.e1" e2="DDI-PubMed.31411489.s5.e1" /><pair ddi="false" e1="DDI-PubMed.31411489.s5.e1" e2="DDI-PubMed.31411489.s5.e2" /></sentence><sentence text=" Conclusion: Ultrasensitive quantification of yohimbine and its metabolite enables the determination of their concentrations in plasma after microdosing which would be applicable to use in CYP2D6 phenotyping"><entity charOffset="46-55" id="DDI-PubMed.31411489.s6.e0" text="yohimbine" /></sentence><sentence text="" /></document>